Wyvern Pharmaceuticals Revenue

Biotechnology Research • Calgary, Alberta, Canada • 1-10 Employees

Wyvern Pharmaceuticals revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$821,328
Total funding	No funding

Key Contact at Wyvern Pharmaceuticals

Brad Thompson

Chief Executive Officer

Company overview

Headquarters	Calgary, Alberta, Canada
Website	wyvernpharma.com
NAICS	541714
Keywords	Life Sciences, Biotechnology, Pharmaceuticals, Drug Development, Healthcare, R&D, Rheumatoid Arthritis, Sirna, Immunotherapy, Cancer, Infectious Disease, Autoimmune Disease, Gene Therapy, Ctla4, Tlr3, Immune Modulation
Founded	2017
Employees	1-10

Wyvern Pharmaceuticals Email Formats

Wyvern Pharmaceuticals uses 1 email format. The most common is {2char} (e.g., {2char}@wyvernpharma.com), used 100% of the time.

Format	Example	Percentage
{2char}	{2char}@wyvernpharma.com	100%

About Wyvern Pharmaceuticals

Founded in 2017, Wyvern Pharmaceuticals Inc. is a privately held biopharmaceutical company headquartered in Calgary, Canada. Our executive team brings together decades of experience in drug development and taking new therapies to market. Together, we aim to deliver meaningful quality of life and lifespan extension benefits to patient populations with serious unmet treatment needs. Our proprietary technologies use gene therapy to safely and effectively treat serious illnesses, including autoimmune disorders, cancer and infectious diseases. Our lead agent is WYV-RA, a gene therapy that treats rheumatoid arthritis by upregulating CTLA4 in target tissues, and downregulating TNF so that it is not excreted by the target tissues. Planning for a randomized clinical study in RA patients is now underway. Our follow-on agent is WYV-ONC, a gene therapy that treats cancer by upregulating TLR3 in target tumours and overcomes immunotherapy treatment resistance when used in combination with immunotherapies such as checkpoint inhibitors.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Wyvern Pharmaceuticals has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Wyvern Pharmaceuticals has never raised funding before.

Wyvern Pharmaceuticals Tech Stack

Discover the technologies and tools that power Wyvern Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Bootstrap

UI frameworks

Google Analytics

Analytics

Google Font API

Font scripts

Frequently asked questions

Wyvern Pharmaceuticals is located in Calgary, Alberta, CA.

Wyvern Pharmaceuticals generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.

Wyvern Pharmaceuticals has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Wyvern Pharmaceuticals was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Wyvern Pharmaceuticals has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Wyvern Pharmaceuticals

Brad Thompson

Chief Executive Officer

4.8

40,000 users